Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 USD | -0.75% | -4.15% | -6.00% |
17/05 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.00% | 1.87Cr | |
+37.78% | 71TCr | |
+32.82% | 58TCr | |
-3.51% | 36TCr | |
+19.94% | 33TCr | |
+5.14% | 29TCr | |
+16.64% | 24TCr | |
-4.13% | 21TCr | |
+10.63% | 21TCr | |
+9.32% | 17TCr |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Wedbush Adjusts Kala Pharmaceuticals' Price Target to $3 From $6, Keeps Outperform Rating